Elsa – FDA AI Tool: Navigating Efficiency...

By João L. Carapinha

June 10, 2025

The U.S. Food and Drug Administration (FDA) has launched the FDA AI Tool Insights known as Elsa. This generative AI tool streamlines internal workflows, including clinical protocol reviews, adverse event summarization, and inspection targeting. Co...
What are the Plans and Implications for Keytruda´s Biosimilar
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
Alzheimer’s Blood Test Diagnostics: FDA Clears First Blood Test for Ear...
EU Establishes Expert Panel for Orphan Paediatric Devices
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration
Navigating EU AI Act Healthcare Compliance: Proactive Steps for Ethical AI In...
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...